| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner | Director +2 more
43 companies
Ra Capital Management, L.P. is a Director, 10% Owner at Wave Life Sciences Ltd. with holdings across 43 companies. Recent SEC Form 4 filings include 15 buys and 0 sells.
Estimated insider holdings value: $3503.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 13, 2016 | ACRS Aclaris Therapeutics, Inc. | 10% Owner | Buy | 15,637 | $19.10 | $298,737.76 | +0.2% | |
| Nov 16, 2015 | WVE Wave Life Sciences Ltd. | Director, 10% Owner | Buy | 1,875,000 | $16.00 | $30,000,000.00 | +36.0% | |
| Oct 29, 2015 | ACRS Aclaris Therapeutics, Inc. | 10% Owner | Buy | 244,200 | $14.00 | $3,418,800.00 | +5.1% | |
| Oct 22, 2015 | ACRS Aclaris Therapeutics, Inc. | 10% Owner | Buy | 5,410 | $14.03 | $75,882.82 | +0.2% | |
| Oct 21, 2015 | ACRS Aclaris Therapeutics, Inc. | 10% Owner | Buy | 34,999 | $14.89 | $521,095.36 | +0.5% | |
| Oct 14, 2015 | ACRS Aclaris Therapeutics, Inc. | 10% Owner | Buy | 42,813 | $14.06 | $601,792.37 | +1.9% | |
| Oct 8, 2015 | ACRS Aclaris Therapeutics, Inc. | 10% Owner | Buy | 2,237,130 | $10.86 | $24,289,919.53 | +41.9% |